Variations in TcdB Activity and the Hypervirulence of Emerging Strains of
Hypervirulent strains of Clostridium difficile have emerged over the past decade, increasing the morbidity and mortality of patients infected by this opportunistic pathogen. Recent work suggested the major C. difficile virulence factor, TcdB, from hypervirulent strains (TcdBHV) was more cytotoxic in vitro than TcdB from historical strains (TcdBHIST). The current study investigated the in vivo impact of altered TcdB tropism, and the underlying mechanism responsible for the differences in activity between the two forms of this toxin. A combination of protein sequence analyses, in vivo studies using a Danio rerio model system, and cell entry combined with fluorescence assays were used to define the critical differences between TcdBHV and TcdBHIST. Sequence analysis found that TcdB was the most variable protein expressed from the pathogenicity locus of C. difficile. In line with these sequence differences, the in vivo effects of TcdBHV were found to be substantially broader and more pronounced than those caused by TcdBHIST. The increased toxicity of TcdBHV was related to the toxin's ability to enter cells more rapidly and at an earlier stage in endocytosis than TcdBHIST. The underlying biochemical mechanism for more rapid cell entry was identified in experiments demonstrating that TcdBHV undergoes acid-induced conformational changes at a pH much higher than that of TcdBHIST. Such pH-related conformational changes are known to be the inciting step in membrane insertion and translocation for TcdB. These data provide insight into a critical change in TcdB activity that contributes to the emerging hypervirulence of C. difficile.
Vyšlo v časopise:
Variations in TcdB Activity and the Hypervirulence of Emerging Strains of. PLoS Pathog 6(8): e32767. doi:10.1371/journal.ppat.1001061
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1001061
Souhrn
Hypervirulent strains of Clostridium difficile have emerged over the past decade, increasing the morbidity and mortality of patients infected by this opportunistic pathogen. Recent work suggested the major C. difficile virulence factor, TcdB, from hypervirulent strains (TcdBHV) was more cytotoxic in vitro than TcdB from historical strains (TcdBHIST). The current study investigated the in vivo impact of altered TcdB tropism, and the underlying mechanism responsible for the differences in activity between the two forms of this toxin. A combination of protein sequence analyses, in vivo studies using a Danio rerio model system, and cell entry combined with fluorescence assays were used to define the critical differences between TcdBHV and TcdBHIST. Sequence analysis found that TcdB was the most variable protein expressed from the pathogenicity locus of C. difficile. In line with these sequence differences, the in vivo effects of TcdBHV were found to be substantially broader and more pronounced than those caused by TcdBHIST. The increased toxicity of TcdBHV was related to the toxin's ability to enter cells more rapidly and at an earlier stage in endocytosis than TcdBHIST. The underlying biochemical mechanism for more rapid cell entry was identified in experiments demonstrating that TcdBHV undergoes acid-induced conformational changes at a pH much higher than that of TcdBHIST. Such pH-related conformational changes are known to be the inciting step in membrane insertion and translocation for TcdB. These data provide insight into a critical change in TcdB activity that contributes to the emerging hypervirulence of C. difficile.
Zdroje
1. HallIC
O'TooleE
1935 Intestinal flora in new-born infants: with a description of a new pathogenic anaerobe, Bacillus difficilis. Am J Dis Child 49 390 402
2. GeorgeRH
SymondsJM
DimockF
BrownJD
ArabiY
1978 Identification of Clostridium difficile as a cause of pseudomembranous colitis. Br Med J 1 695
3. ChangTW
BartlettJG
GorbachSL
OnderdonkAB
1978 Clindamycin-induced enterocolitis in hamsters as a model of pseudomembranous colitis in patients. Infect Immun 20 526 529
4. BartlettJG
1992 Antibiotic-associated diarrhea. Clin Infect Dis 15 9
5. MutoCA
PokrywkaM
ShuttK
MendelsohnAB
NouriK
2005 A Large Outbreak of Clostridium difficile-Associated Disease With an Unexpected Proportion of Deaths and Colectomies at a Teaching Hospital Following Increased Fluoroquinolone Use. Infection Control and Hospital Epidemiology 26 273 280
6. LooVG
PoirierL
MillerMA
OughtonM
LibmanMD
2005 A Predominantly Clonal Multi-Institutional Outbreak of Clostridium difficile-Associated Diarrhea with High Morbidity and Mortality. N Engl J Med 353 2442 2449
7. McDonaldLC
KillgoreGE
ThompsonA
OwensRCJr
KazakovaSV
2005 An Epidemic, Toxin Gene-Variant Strain of Clostridium difficile. N Engl J Med 353 2433 2441
8. WarnyM
PepinJ
FangA
KillgoreG
ThompsonA
2005 Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. The Lancet 366 1079 1084
9. AkerlundT
PerssonI
UnemoM
NorenT
SvenungssonB
2008 Increased Sporulation Rate of Epidemic Clostridium difficile Type 027/NAP1. J Clin Microbiol 46 1530 1533
10. MacCannellDR
LouieTJ
GregsonDB
LaverdiereM
LabbeA-C
2006 Molecular Analysis of Clostridium difficile PCR Ribotype 027 Isolates from Eastern and Western Canada. J Clin Microbiol 44 2147 2152
11. GericB
RupnikM
GerdingDN
GrabnarM
JohnsonS
2004 Distribution of Clostridium difficile variant toxinotypes and strains with binary toxin genes among clinical isolates in an American hospital. J Med Microbiol 53 887 894
12. GoncalvesC
DecreD
BarbutF
BurghofferB
PetitJ-C
2004 Prevalence and Characterization of a Binary Toxin (Actin-Specific ADP-Ribosyltransferase) from Clostridium difficile. J Clin Microbiol 42 1933 1939
13. SchwanC
StecherBr
TzivelekidisT
van HamM
RohdeM
2009 Clostridium difficile Toxin CDT Induces Formation of Microtubule-Based Protrusions and Increases Adherence of Bacteria. PLoS Pathog 5 e1000626
14. BourgaultA-M
LamotheF
LooVG
PoirierL
the CDAD-CSI Study Group 2006 In Vitro Susceptibility of Clostridium difficile Clinical Isolates from a Multi-Institutional Outbreak in Southern Quebec, Canada. Antimicrob Agents Chemother 50 3473 3475
15. DrudyD
QuinnT
O'MahonyR
KyneL
O'GaoraP
2006 High-level resistance to moxifloxacin and gatifloxacin associated with a novel mutation in gyrB in toxin-A-negative, toxin-B-positive Clostridium difficile. J Antimicrob Chemother 58 1264 1267
16. DrudyD
KyneL
ROMS
Fanning
2007 gyrA mutations in fluoroquinolone-resistant Clostridium difficile PCR-027. Emerg Infect Dis 13 2
17. StablerR
HeM
DawsonL
MartinM
ValienteE
2009 Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biology 10 R102
18. TanKS
WeeBY
SongKP
2001 Evidence for holin function of tcdE gene in the pathogenicity of Clostridium difficile. J Med Microbiol 50 613 619
19. HammondGA
JohnsonJL
1995 The toxigenic element of Clostridium difficile strain VPI 10463. Microbial Pathogenesis 19 203 213
20. JustI
SelzerJ
WilmM
Eichel-StreiberCv
MannM
1995 Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 375 500 503
21. Eichel-StreiberCv
Dagmar Meyer zu HeringdorfEH
Sabine Sartingen
1995 Closing in on the toxic domain through analysis of a variant Clostridium difficile cytotoxin B. Mol Microbiol 17 313 321
22. FaustC
YeB
SongK-P
1998 The Enzymatic Domain of Clostridium difficile Toxin A Is Located within Its N-Terminal Region. Biochemical and Biophysical Research Communications 251 100 105
23. HofmannF
BuschC
PrepensU
JustI
AktoriesK
1997 Localization of the Glucosyltransferase Activity of Clostridium difficile Toxin B to the N-terminal Part of the Holotoxin. J Biol Chem 272 11074 11078
24. BuschC
HofmannF
SelzerJr
MunroS
JeckelD
1998 A Common Motif of Eukaryotic Glycosyltransferases Is Essential for the Enzyme Activity of Large Clostridial Cytotoxins. J Biol Chem 273 19566 19572
25. BuschC
HofmannF
GerhardR
AktoriesK
2000 Involvement of a Conserved Tryptophan Residue in the UDP-Glucose Binding of Large Clostridial Cytotoxin Glycosyltransferases. J Biol Chem 275 13228 13234
26. HofmannF
BuschC
AktoriesK
1998 Chimeric Clostridial Cytotoxins: Identification of the N-Terminal Region Involved in Protein Substrate Recognition. Infect Immun 66 1076 1081
27. RupnikM
PabstS
RupnikM
von Eichel-StreiberC
UrlaubH
2005 Characterization of the cleavage site and function of resulting cleavage fragments after limited proteolysis of Clostridium difficile toxin B (TcdB) by host cells. Microbiology 151 199 208
28. ReinekeJ
TenzerS
RupnikM
KoschinskiA
HasselmayerO
2007 Autocatalytic cleavage of Clostridium difficile toxin B. Nature 446 415 419
29. EgererM
GiesemannT
JankT
SatchellKJF
AktoriesK
2007 Auto-catalytic Cleavage of Clostridium difficile Toxins A and B Depends on Cysteine Protease Activity. J Biol Chem 282 25314 25321
30. DingleT
WeeS
MulveyGL
GrecoA
KitovaEN
2008 Functional properties of the carboxy-terminal host cell-binding domains of the two toxins, TcdA and TcdB, expressed by Clostridium difficile. Glycobiology 18 698 706
31. WrenBW
1991 A family of clostridial and streptococcal ligand-binding proteins with conserved C-terminal repeat sequences. Mol Microbiol 5 797 803
32. Eichel-StreiberC
Laufenberg-FeldmannR
SartingenS
SchulzeJ
SauerbornM
1992 Comparative sequence analysis of the Clostridium difficile toxins A and B. Molecular and General Genetics 233 260 268
33. von Eichel-StreiberC
SauerbornM
1990 Clostridium difficile toxin A carries a C-terminal repetitive structure homologous to the carbohydrate binding region of streptococcal glycosyltransferases. Gene 96 107 113
34. StablerRA
GerdingDN
SongerJG
DrudyD
BrazierJS
2006 Comparative phylogenomics of Clostridium difficile reveals clade specificity and microevolution of hypervirulent strains. J Bacteriol 188 7297 7305
35. von Eichel-StreiberC
SauerbornM
KuramitsuHK
1992 Evidence for a modular structure of the homologous repetitive C-terminal carbohydrate-binding sites of Clostridium difficile toxins and Streptococcus mutans glucosyltransferases. J Bacteriol 174 6707 6710
36. Albesa-JovÈD
BertrandT
CarpenterEP
SwainGV
LimJ
Four Distinct Structural Domains in Clostridium difficile Toxin B Visualized Using SAXS. Journal of Molecular Biology 396 1260 1270
37. HammEE
VothDE
BallardJD
2006 Identification of Clostridium difficile toxin B cardiotoxicity using a zebrafish embryo model of intoxication. Proc Natl Acad Sci U S A 103 14176 14181
38. ClaycombWC
LansonNA
StallworthBS
EgelandDB
DelcarpioJB
1998 HL-1 cells: A cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci U S A 95 2979 2984
39. BallardJD
CollierRJ
StarnbachMN
1996 Anthrax toxin-mediated delivery of a cytotoxic T-cell epitope in vivo. Proc Natl Acad Sci U S A 93 12531 12534
40. SpyresLM
Qa'DanM
MeaderA
TomasekJJ
HowardEW
2001 Cytosolic Delivery and Characterization of the TcdB Glucosylating Domain by Using a Heterologous Protein Fusion. Infect Immun 69 599 601
41. Qa'DanM
SpyresLM
BallardJD
2000 pH-Induced Conformational Changes in Clostridium difficile Toxin B. Infect Immun 68 2470 2474
42. BarthH
PfeiferG
HofmannF
MaierE
BenzR
2001 Low pH-induced Formation of Ion Channels by Clostridium difficile Toxin B in Target Cells. J Biol Chem 276 10670 10676
43. LyrasD
O'ConnorJR
HowarthPM
SambolSP
CarterGP
2009 Toxin B is essential for virulence of Clostridium difficile. Nature 458 1176 1179
44. RazaqN
SambolS
NagaroK
ZukowskiW
CheknisA
2007 Infection of Hamsters with Historical and Epidemic BI Types of Clostridium difficile. J Infect Dis 196 1813 1819
45. RupnikM
GrabnarM
GericB
2003 Binary toxin producing Clostridium difficile strains. Anaerobe 9 289 294
46. BarbutF
DecreD
LalandeV
BurghofferB
NoussairL
2005 Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains. J Med Microbiol 54 181 185
47. GericB
CarmanRJ
RupnikM
GenheimerCW
SambolSP
2006 Binary Toxin Producing, Large Clostridial Toxin Negative Clostridium difficile Strains Are Enterotoxic but Do Not Cause Disease in Hamsters. J Infect Dis 193 1143 1150
48. MurrayR
BoydD
LevettP
MulveyM
AlfaM
2009 Truncation in the tcdC region of the Clostridium difficile PathLoc of clinical isolates does not predict increased biological activity of Toxin B or Toxin A. BMC Infectious Diseases 9 103
49. HeM
SebaihiaM
LawleyTD
StablerRA
DawsonLF
2010 Evolutionary dynamics of Clostridium difficile over short and long time scales. Proc Natl Acad Sci U S A: 107 7527 7532
50. VothDE
HammEE
NguyenLG
TuckerAE
SallesII
2005 Bacillus anthracis oedema toxin as a cause of tissue necrosis and cell type-specific cytotoxicity. Cell Microbiol 7 1139 1149
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 8
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Contribution of Coagulases towards Disease and Protective Immunity
- Early Severe Inflammatory Responses to Uropathogenic Predispose to Chronic and Recurrent Urinary Tract Infection
- The Transcription Factor Rbf1 Is the Master Regulator for -Mating Type Controlled Pathogenic Development in
- Immune Modulation with Sulfasalazine Attenuates Immunopathogenesis but Enhances Macrophage-Mediated Fungal Clearance during Pneumonia